Cyclo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyclo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cyclo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $246K, a 400% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $246K +$196K +400% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $569K +$516K +967% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $891K +$889K +60509% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $44.8K +$39.2K +691% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $49.1K +$39.1K +388% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $53.4K +$38.9K +269% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.47K -$16.2K -91.7% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $5.67K -$16.4K -74.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $10.1K -$16.4K -61.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $14.5K -$16.4K -53.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $17.6K -$16.4K -48.1% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $22K -$16.3K -42.5% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $26.5K -$16.1K -37.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $30.9K -$15.9K -34% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $34K -$17K -33.3% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $38.3K -$16.9K -30.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $42.5K -$17K -28.6% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $46.8K -$17K -26.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $51K Dec 31, 2019 10-K 2021-03-12
Q3 2019 $55.3K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $59.5K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $63.8K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.